Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For children:
- The child has been diagnosed with medulloblastoma (a type of brain tumor) that has come back, confirmed by a scan or tissue sample
- The child is 18 years old or younger at the time of joining the trial
- The child is currently receiving active treatment for the returned cancer
- The child is expected to live for at least 3 months
For parents/caregivers:
- The parent or caregiver is the main person responsible for managing the child's medications and treatment appointments
- The parent or caregiver is at least 18 years old
- The parent or caregiver can read and understand study materials written in English
- The parent or caregiver is willing to fill out study questionnaires and take part in assessments
Who may not be able to join:
- The child is only receiving comfort or end-of-life (hospice) care, rather than active treatment
- The parent or caregiver has a serious mental health condition or difficulty with thinking or understanding that would prevent them from giving informed consent or completing questionnaires
- The child is already taking part in another clinical trial that could affect how adherence to treatment is measured
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18980606446
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Treatment Adherence Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.